Scheffler, J. M., Drevinge, C., Lindholm, C., Gjertsson, I., Lend, K., Hetland, M. L., . . . Islander, U. Circulating Baseline CXCR3+Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis. Wiley.
Chicago Style (17th ed.) CitationScheffler, Julia M., et al. Circulating Baseline CXCR3+Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis. Wiley.
MLA (9th ed.) CitationScheffler, Julia M., et al. Circulating Baseline CXCR3+Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis. Wiley.
Warning: These citations may not always be 100% accurate.